# Abiomed acquires Breethe to expand ECMO product portfolio

Abiomed, maker of the Impella heart pump, acquired Breethe, developer of a novel ECMO system, to complement its product portfolio for patients with respiratory failure.

- Type: Acquisition
- Announced: 2020-04-29
- Where: Halethorpe, Maryland, United States
- Status: completed
- Products: ECMO system, Impella heart pump
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Abiomed](https://endata.com/companies/9846.md) (acquirer)
- [Breethe](https://endata.com/companies/46883.md) (target)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20200429005975/en/Abiomed-Expands-Product-Portfolio-with-Acquisition-of-Cardiopulmonary-Support-Technology-ECMO-to-Improve-Outcomes-for-Patients), 2020-04-29: "Abiomed has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed's product portfolio."
- [technical.ly](https://technical.ly/startups/university-maryland-baltimore-born-medical-device-company-lung-breethe-acquired-by-abiomed/), 2020-05-01: "Abiomed is the best positioned company to build on the legacy of what we started."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.